Oren Gottfried, MD @OGdukeneurosurg Great one pager on managing Pain. pic.twitter.com/2RbqCu7BRm 8/9/24, 6:23 AM Joseph Thornton
Author Archives: Joseph Thornton MD
Post by JAMA Neurology on X. F m. D
JAMA Neurology @JAMANeuro In patients with patients with functional movement disorders, multidisciplinary treatment (physiotherapy plus CBT) effectively improves FMD symptoms and physical aspects of patients’ quality of life. ja.ma/3A4WrTR pic.twitter.com/isVHFUQC4J 8/5/24, 12:00 PM Joseph Thornton
Post by Chris Palmer, MD on X trauma and mitochondria
Chris Palmer, MD @ChrisPalmerMD How does trauma increase the risk of obesity, T2 diabetes, and heart disease? More importantly, what can we do to mitigate these risks? You’ll need to understand metabolism and mitochondria to answer these questions. #BrainEnergy 8/5/24, 6:58 AM Joseph Thornton
Post by WalidoNeuroPedia on X
WalidoNeuroPedia @NeuroWalid Lewy body dementia infographic #neurocognition #neurotip pic.twitter.com/ADTYdBkII8 8/4/24, 11:47 AM Joseph Thornton
Post by AMA on X blood test Alzheimer’s
AMA @AmerMedicalAssn How is #Alzheimer‘s diagnosed? Is there a new blood test for #coloncancer? Is #WestNile virus deadly and can it be cured? How bad is #COVID19 right now? Answers to these questions and more in this episode of AMA Update. spr.ly/6016YGtlA 8/4/24, 5:00 PM Joseph Thornton
Post by Michael Okun on X. Functional move disorders
Michael Okun @MichaelOkun The final slide of the 5 day Aspen movement disorders course delivered by Professor @AlbertoEspay delivers everything you need to know about the challenges in functional movement disorders in one slide. @movedisorder Aspen course faculty drops the ‘mic.’ See you in 2025. pic.twitter.com/bzQS9eXsPJ 8/3/24, 11:17 AM Joseph Thornton
Post by JAMA on X. Administrative harm
JAMA @JAMA_current JAMA Medical News in Brief: Administrative Harm Widespread in Medicine, Study Finds ja.ma/46sRsJ3 7/29/24, 10:00 PM Joseph Thornton
Screenshot 2024-07-28 Okun on biomarkers for Alzheimer’s and Parkinson’s
Joseph Thornton
Post by JAMA on X. Obesity meds overview
JAMA @JAMA_current Most viewed in the last 7 days from @JAMA_current: Review examines the safety and efficacy of various antiobesity medications in conjunction with lifestyle modification according to their mechanism of action. ja.ma/46jxwbn pic.twitter.com/2xGuAZh22p 7/27/24, 7:00 AM Joseph Thornton
Post by Science Magazine GLP 1full benefits. Neuro etc
Science Magazine @ScienceMagazine A new #SciencePerspective highlights the growing body of evidence that hints at the potential of GLP-1–based medications in treating conditions other than diabetes and obesity, including cardiovascular disease and neurodegenerative disorders. Read more: scim.ag/7N0 pic.twitter.com/GrJExkhDpx 7/25/24, 5:00 AM Joseph Thornton
Gator Psychiatry 